These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7000163)

  • 1. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations.
    Johnson IR
    Br J Obstet Gynaecol; 1980 Oct; 87(10):883-8. PubMed ID: 7000163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during the normal menstrual cycle.
    Johnson IR
    Br J Obstet Gynaecol; 1980 Oct; 87(10):875-82. PubMed ID: 7000162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
    Umapathysivam K; Jones WR
    Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
    Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
    Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An incremental-dose combined oestrogen-progestogen oral contraceptive: cycle control and endometrial changes.
    Khoo SK; McKenna H
    Aust N Z J Obstet Gynaecol; 1980 Aug; 20(3):168-71. PubMed ID: 6936018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
    Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
    Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) during normal menstrual and combined oral contraceptive cycles and relationship to immunohistological localization.
    Wood PL; Walker RA; Bell SC
    Hum Reprod; 1989 Feb; 4(2):140-6. PubMed ID: 2918066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives.
    Schumacher M; Nanninga A; Delfs T; Mukhopadhyay AK; Leidenberger FA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):617-23. PubMed ID: 1639960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensinogen reaction during pregnancy and oral contraception: estimation of kinetic parameters by an autologous plasma renin assay.
    Daniels CR; Eisen V; Slater JD
    J Endocrinol; 1987 Mar; 112(3):465-72. PubMed ID: 3549958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J
    Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
    Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
    Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.